Bioventus share price today

(BVS)

Bioventus share price is $10.67 & ₹906.69 as on 21 Dec 2024, 2.30 'hrs' IST

$10.67

▲

0.15

(1.43%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Bioventus share price in Dollar and Rupees. Guide to invest in Bioventus from India. Also see the sentimental analysis on Indian investors investing in Bioventus. Get details on the Indian mutual funds that are investing in Bioventus. Get Analyst recommendations and forecasts along with all the Bioventus's financials.

Bioventus share price movements

Today's Low: $10.27
Today's High: $10.80
$10.67
3.75%
Downside
Day's Volatility :4.91%
Upside
1.2%
52 Weeks Low: $3.90
52 Weeks High: $14.38
$10.67
63.45%
Downside
52 Weeks Volatility :72.88%
Upside
25.8%

Bioventus Returns

Period	Bioventus Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.07%	-11.1%	0.0%
6 Months	90.88%	-6.0%	0.0%
1 Year	104.02%	2.7%	0.0%
3 Years	-22.34%	0.6%	-19.7%

Bioventus Key Statistics

in dollars & INR

Previous Close	$10.52
Open	$10.27
Today's High	$10.8
Today's Low	$10.27
Market Capitalization	$687.7M
Today's Volume	$509.9K
52 Week High	$14.38
52 Week Low	$3.9
Revenue TTM	$555.1M
EBITDA	$50.4M
Earnings Per Share (EPS)	$-0.61
Profit Margin	-7.11%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-24.76%

How to invest in Bioventus from India?

It is very easy for Indian residents to invest directly in Bioventus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioventus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioventus or BVS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioventus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioventus shares which would translate to 0.080 fractional shares of Bioventus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bioventus, in just a few clicks!

Returns in Bioventus for Indian investors in Rupees

Investment Value

₹1,00,000

Bioventus investment value today

Current value as on today

₹2,06,211

Returns

₹1,06,211

(+106.21%)

Returns from Bioventus Stock

₹1,04,015 (+104.02%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Bioventus

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Bioventus on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 0% more investors are searching Bioventus in the last 30 days versus the previous period.

Global Institutional Holdings in Bioventus

Essex Woodlands Health Ventures
19.92%
Juniper Investment Co, LLC
10.62%
Nantahala Capital Management, LLC
6.66%
BlackRock Inc
3.63%
Vanguard Group Inc
3.17%
Morgan Stanley - Brokerage Accounts
1.54%

Analyst Recommendation on Bioventus

Buy

71%Buy

14%Hold

14%Sell

Based on 7 Wall street analysts offering stock ratings for Bioventus(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bioventus

What analysts predicted

Upside of 40.58%

Current:

$10.67

Target:

$15.00

Insights on Bioventus

Price Movement
In the last 6 months, BVS stock has moved up by 88.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 151.21M → 138.96M (in $), with an average decrease of 8.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -23.99M → -4.82M (in $), with an average increase of 397.4% per quarter
BVS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 138.1%

Bioventus Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$319.2M	↑ 25.83%
Net Income	$-12.2M	↓ 64.21%
Net Profit Margin	-3.82%	↑ 9.63%

	FY19	Y/Y Change
Revenue	$340.1M	↑ 6.57%
Net Income	$6.9M	↓ 156.12%
Net Profit Margin	2.01%	↑ 5.83%

	FY20	Y/Y Change
Revenue	$321.2M	↓ 5.58%
Net Income	$16.4M	↑ 139.54%
Net Profit Margin	5.11%	↑ 3.1%

	FY21	Y/Y Change
Revenue	$430.9M	↑ 34.17%
Net Income	$9.6M	↓ 41.59%
Net Profit Margin	2.22%	↓ 2.89%

	FY22	Y/Y Change
Revenue	$512.1M	↑ 18.85%
Net Income	$-213.4M	↓ 2326.07%
Net Profit Margin	-41.67%	↓ 43.89%

	FY23	Y/Y Change
Revenue	$512.3M	↑ 0.04%
Net Income	$-156.2M	↓ 26.79%
Net Profit Margin	-30.49%	↑ 11.18%

	Q2 FY23	Q/Q Change
Revenue	$137.1M	↑ 15.13%
Net Income	$-3.7M	↓ 96.32%
Net Profit Margin	-2.69%	↑ 81.32%

	Q3 FY23	Q/Q Change
Revenue	$120.8M	↓ 11.87%
Net Income	$-7.3M	↑ 98.4%
Net Profit Margin	-6.05%	↓ 3.36%

	Q4 FY23	Q/Q Change
Revenue	$135.4M	↑ 12.11%
Net Income	$-6.1M	↓ 16.53%
Net Profit Margin	-4.5%	↑ 1.55%

	Q1 FY24	Q/Q Change
Revenue	$129.5M	↓ 4.41%
Net Income	$-4.6M	↓ 25.03%
Net Profit Margin	-3.53%	↑ 0.97%

	Q2 FY24	Q/Q Change
Revenue	$151.2M	↑ 16.81%
Net Income	$-24.0M	↑ 424.99%
Net Profit Margin	-15.87%	↓ 12.34%

	Q3 FY24	Q/Q Change
Revenue	$139.0M	↓ 8.1%
Net Income	$-4.8M	↓ 79.89%
Net Profit Margin	-3.47%	↑ 12.4%

	FY18	Y/Y Change
Profit	$235.0M	↑ 31.06%

	FY19	Y/Y Change
Profit	$249.2M	↑ 6.04%

	FY20	Y/Y Change
Profit	$233.5M	↓ 6.29%

	FY21	Y/Y Change
Profit	$302.7M	↑ 29.63%

	FY22	Y/Y Change
Profit	$331.1M	↑ 9.37%

	FY23	Y/Y Change
Profit	$328.2M	↓ 0.87%

	Q2 FY23	Q/Q Change
Profit	$89.1M	↑ 20.57%

	Q3 FY23	Q/Q Change
Profit	$78.9M	↓ 11.53%

	Q4 FY23	Q/Q Change
Profit	$84.2M	↑ 6.78%

	Q1 FY24	Q/Q Change
Profit	$86.6M	↑ 2.88%

	Q2 FY24	Q/Q Change
Profit	$101.6M	↑ 17.26%

	Q3 FY24	Q/Q Change
Profit	$93.6M	↓ 7.9%

	FY18	Y/Y Change
Operating Cash Flow	$45.2M	↑ 138.83%
Investing Cash Flow	$-6.1M	↓ 89.86%
Financing Cash Flow	$-13.3M	↓ 142.42%

	FY19	Y/Y Change
Operating Cash Flow	$40.7M	↓ 9.9%
Investing Cash Flow	$-7.9M	↑ 29.68%
Financing Cash Flow	$-11.0M	↓ 17.39%

	FY20	Y/Y Change
Operating Cash Flow	$71.8M	↑ 76.35%
Investing Cash Flow	$-20.5M	↑ 159.1%
Financing Cash Flow	$-29.6M	↑ 170.01%

	FY21	Y/Y Change
Operating Cash Flow	$23.0M	↓ 67.98%
Investing Cash Flow	$-283.8M	↑ 1284.2%
Financing Cash Flow	$273.4M	↓ 1024.52%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$10.8M	↑ 333.53%
Investing Cash Flow	$33.5M	↓ 322.35%
Financing Cash Flow	$-62.2M	↓ 327.35%

Bioventus Technicals Summary

Sell

Neutral

Buy

Bioventus is currently in a neutral trading position according to technical analysis indicators.

Bioventus Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bioventus Inc	-7.3%	90.88%	104.02%	-22.34%	-44.46%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bioventus Inc	9.44	NA	2.14	0.41	-0.25	0.02	NA	2.28
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bioventus Inc	Buy	$687.7M	-44.46%	9.44	-7.11%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Bioventus

bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. bioventus accomplishes this with its orthobiologic products for musculoskeletal healing, regeneration and related biosurgery that engage and enhance the body’s natural healing processes. the company has two product portfolios for orthobiologics, bioventus active healing therapies and bioventus surgical, which are created through a combination of internal product development, product/business acquisition, and distribution agreements. established in 2012, bioventus is privately held and headquartered in durham, nc. the company has nearly 600 employees worldwide and its international headquarters is in hoofddorp, the netherlands. bioventus also has offices in memphis, tn, australia and canada, and a research and development site is located in boston. bioventus works with patients, payers and health care providers throughout the world, and generat

Organization	Bioventus
Employees	1030
CEO	Mr. Mark L. Singleton
Industry	Healthcare

Management People of Bioventus

Name	Title
Mr. Mark L. Singleton	Senior VP & CFO
Mr. Anthony D'Adamio J.D.	Senior VP, General Counsel & Corporate Secretary
Mr. Robert E. Claypoole	President, CEO & Director
Mr. Mike Crowe B.S., M.B.A.	Senior Vice President of Operations
Mr. David Crawford	Vice President of Investor Relations & Treasurer
Ms. Katrina J. Church J.D.	Senior VP & Chief Compliance Officer
Ms. Helen Leupold	Senior VP & Chief Human Resources Officer
Mr. Larry Chen	Managing Director of China & Asia Pacific

Important FAQs about investing in Bioventus from India :

What is Bioventus share price today?

Bioventus share price today stands at $10.67, Open: $10.27 ; Previous Close: $10.52 ; High: $10.80 ; Low: $10.27 ; 52 Week High: $14.38 ; 52 Week Low: $3.90. The stock opens at $10.27, after a previous close of $10.52. The stock reached a daily high of $10.80 and a low of $10.27, with a 52-week high of $14.38 and a 52-week low of $3.90.

Can Indians buy Bioventus shares?

Yes, Indians can invest in the Bioventus (BVS) from India.

With INDmoney, you can buy Bioventus at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bioventus at zero transaction cost.

How can I buy Bioventus shares from India?

It is very easy to buy Bioventus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioventus be purchased?

Yes, you can buy fractional shares of Bioventus with INDmoney app.

What are the documents required to start investing in Bioventus stocks?

To start investing in Bioventus, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.